As of 2025-06-21, the EV/EBITDA ratio of ImmunoGen Inc (IMGN) is -105.37. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. IMGN's latest enterprise value is 8,216.60 mil USD. IMGN's TTM EBITDA according to its financial statements is -77.98 mil USD. Dividing these 2 quantities gives us the above IMGN EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 12.5x - 13.9x | 13.4x |
| Forward P/E multiples | 22.3x - 30.0x | 25.4x |
| Fair Price | (4.40) - (2.06) | (3.60) |
| Upside | -114.1% - -106.6% | -111.5% |
| Date | EV/EBITDA |